Delivering regulated AI at scale for pharma | White paper

Regulated AI in pharmaceutical companies doesn’t have to stall under GxP compliance requirements. Yet many organizations still face an AI bottleneck caused by manual validation, fragmented governance, and document-heavy controls.

Delivering Regulated AI at Scale for Pharmaceutical Companies is a practical white paper for pharmaceutical industry leaders who need to accelerate AI innovation while maintaining rigorous GxP compliance. Featuring real-world insights from a global, research-driven pharmaceutical organization, this guide shows how pharmaceutical companies can embed governance directly into data pipelines—so compliance no longer slows delivery.

The problem: GxP compliance is slowing regulated AI

Pharmaceutical companies operate under strict Good Practice (GxP) compliance standards. Every data pipeline must be auditable. Every transformation must be explainable. Every output must be reproducible.

In traditional delivery models, proving GxP compliance relies on documentation, reviews, and manual validation cycles. The result:

• Weeks or months of validation delays
• Repeated audit preparation work
• Inconsistent governance across teams
• Increased regulatory risk when moving quickly

As AI initiatives expand across the pharmaceutical industry, this manual model creates a persistent AI bottleneck that limits experimentation, slows production deployment, and reduces scientific impact.

The opportunity: Embed GxP compliance into delivery

The trade-off between speed and compliance only exists in manual delivery models.

This white paper explains how leading pharmaceutical companies are shifting to automated DataOps operating models that:

• Enforce governance as code directly in pipelines
• Capture validation evidence continuously
• Standardize delivery across dev, test, and production
• Make regulated AI compliant by design

Instead of reviewing compliance after deployment, organizations execute GxP compliance inside their regulated AI workflows—eliminating bottlenecks without increasing risk.

Who this guide is for

This guide is designed for leaders across pharmaceutical companies responsible for regulated data and AI delivery, including:

• Data and AI leaders in pharmaceutical organizations
• Analytics and data engineering teams in the pharmaceutical industry
• Platform and enterprise architecture teams
• Product managers overseeing GxP-governed data products

If your organization is struggling to scale regulated AI under GxP compliance without slowing innovation, this guide is for you.

What you'll learn

Inside Delivering Regulated AI at Scale for Pharmaceutical Companies, you’ll learn:

• Why regulated AI initiatives in pharmaceutical companies stall—even with modern cloud tooling
• How manual GxP compliance creates systemic AI bottlenecks
• Why framing delivery as “speed vs. compliance” is a false choice
• How automated DataOps applies proven DevOps principles to regulated AI at scale
• How a leading global pharmaceutical organization shifted to an automated delivery model that enforces governance while increasing speed
• Five practical steps pharmaceutical leaders can take to introduce automation without replatforming

The guide combines operating-model insight, technical strategy, and a real-world pharmaceutical industry case study to help your organization move from slow experimentation to production-scale regulated AI.

Real-world proof: A Global Pharmaceutical Leader

This white paper includes a detailed case study showing how a global, research-driven pharmaceutical organization:

• Standardized governed data pipelines
• Embedded continuous validation into delivery workflows
• Reduced friction between compliance and innovation
• Accelerated AI delivery without compromising GxP compliance

The result: Regulated AI at production scale—without an AI bottleneck.

Eliminate your AI bottleneck. Operationalize GxP at scale.

Learn how pharmaceutical companies can scale regulated AI under GxP compliance—without sacrificing speed, governance, or control.

Download Delivering Regulated AI at Scale for Pharmaceutical Companies to:

• Eliminate AI bottlenecks
• Operationalize GxP compliance in data pipelines
• Increase delivery speed without increasing risk
• Build AI-ready, governed data products at scale

Fill out the form at the top of the page to access your copy today.